sq-11725 has been researched along with Atrial Fibrillation in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiu-Man, C; Gow, RM; Snider, K | 1 |
Leung, TK; Nattel, S; Rivard, L; Schram, G; Shiroshita-Takeshita, A; Sinno, H | 1 |
Horn, HG; Mitrovic, V; Neuss, H; Schlepper, M; Stämmler, G | 1 |
Attuel, P; Coumel, P; Escoubet, B | 1 |
Sung, RJ; Svinarich, JT; Tai, DY | 1 |
Chadda, KD; DiBianco, R; Donohue, DJ; Freitag, JA; Larca, LJ; Lindgren, KM; Morganroth, J; Olukotun, AY; Ronan, JA | 1 |
Liu, L; Nattel, S | 1 |
Zimmers, T | 1 |
Brewington, J; Gore, R; Olukotun, AY; Zoble, RG | 1 |
2 trial(s) available for sq-11725 and Atrial Fibrillation
Article | Year |
---|---|
Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nadolol; Physical Exertion; Propanolamines; Random Allocation; Time Factors | 1984 |
Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Chronic Disease; Circadian Rhythm; Clinical Trials as Topic; Digoxin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nadolol; Random Allocation | 1987 |
7 other study(ies) available for sq-11725 and Atrial Fibrillation
Article | Year |
---|---|
Atrial fibrillation in a LQTS patient with an ICD programmed for managed ventricular pacing: what is the cause?
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Humans; Male; Nadolol; Romano-Ward Syndrome | 2012 |
The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Disease; Diltiazem; Dogs; Electric Stimulation; Flecainide; Models, Animal; Nadolol; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sulfonamides; Vagus Nerve | 2007 |
[Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Heart Rate; Humans; Middle Aged; Nadolol; Propanolamines | 1980 |
Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Tachycardia; Time Factors | 1984 |
Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Nadolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia; Tachycardia, Paroxysmal | 1984 |
Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Atropine; Dogs; Electric Stimulation; Female; Male; Nadolol; Refractory Period, Electrophysiological; Sympathetic Nervous System; Time Factors; Vagus Nerve | 1997 |
Cases in electrocardiography.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Diltiazem; Electrocardiography; Emergency Treatment; Female; Heart Block; Humans; Male; Multiple Trauma; Nadolol; Pain; Recurrence | 2000 |